Abstract
Thyroid nodules are common but the rate of malignancy is only 4–5 % [1, 2]. From 1975 to 2001, the incidence of thyroid cancer in Japan slightly and consistently increased, from 0.5 per 100,000 to 1.7 in men and from 2.1 per 100,000 to 5.9 in women [3]. A careful history is important because it can reveal information that immediately stratifies a patient into a high-risk category. High-risk factors include ionizing radiation to the neck during childhood [4], a history of benign goiter and thyroid nodules [5], and a family history of thyroid cancer. The risk of thyroid cancer in first-degree relatives of patients with differentiated thyroid cancer has been shown to be six times that of the general population [6].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lin JD, Chao TC, Huang BY, Chen ST, Chang HY, Hsueh C. Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology. Thyroid. 2005;15(7):708–17.
Rojeski MT, Gharib H. Nodular thyroid disease. Evaluation and management. N Engl J Med. 1985;313(7):428–36.
Center for Cancer Control and Information Services, National Cancer Center. Cancer incidence (1975–2001). Center for Cancer Control and Information Services, National Cancer Center, Japan; 2006.
Cardis E, Kesminiene A, Ivanov V, et al. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst. 2005;97(10): 724–32.
Franceschi S, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control. 1999;10(6):583–95.
Handkiewcz-Junak D, Banasik T, Kolosza Z, et al. Risk of malignant tumors in first-degree relatives of patients with differentiated thyroid cancer—a hospital based study. Neoplasma. 2006;53(1):67–72.
Crile Jr G. Treatment of carcinomas of the thyroid. In: Young S, Inman DR, editors. Thyroid neoplasia. London, UK: Academic; 1968. p. 39–50.
Lazar V, Bidart JM, Caillou B, et al. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab. 1999;84(9): 3228–34.
Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, DeGroot LJ. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab. 1994;79(1): 98–105.
van Sorge-van Boxtel RA, van Eck-Smit BL, Goslings BM. Comparison of serum thyroglobulin, 131I and 201Tl scintigraphy in the postoperative follow-up of differentiated thyroid cancer. Nucl Med Commun. 1993;14(5):365–72.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Humana Press
About this chapter
Cite this chapter
Yasumatsu, R., Nakashima, T., Komune, S. (2013). Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma Surveillance Counterpoint: Japan. In: Johnson, F., et al. Patient Surveillance After Cancer Treatment. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-969-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-60327-969-7_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-968-0
Online ISBN: 978-1-60327-969-7
eBook Packages: MedicineMedicine (R0)